# Neobe Therapeutics funding rounds and investors

As of 10 Nov 2026, Neobe Therapeutics has raised $6.8M across 1 verified round on record, plus 1 round still being checked; latest: US$6.8 million (£5 million) seed round led by ARC Ventures, announced 10 Nov 2026.

Engineered bacteria designed to break down barriers preventing cancer drugs from effectively reaching solid tumors.

Website: https://neobetherapeutics.com  
Headquarters: London  
Page: https://fireround.dev/companies/neobe-therapeutics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-10 | Seed | US$6.8 million (£5 million) | ARC Ventures | 2048 Ventures, Empirical Ventures, Faber, Macmillan Ventures, Proven Connect | [businesswire.com](https://www.businesswire.com/news/home/20261109750852/en/Neobe-Raises-%246.8-Million-to-Break-Down-the-Barriers-That-Stop-Cancer-Treatments-From-Working), [biospace.com](https://www.biospace.com/press-releases/neobe-raises-6-8-million-to-break-down-the-barriers-that-stop-cancer-treatments-from-working), [eu-startups.com](https://www.eu-startups.com/2026/11/london-based-neobe-raises-e6-1-million-to-engineer-bacteria-that-break-down-barriers-protecting-cancer-tumours) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.